CD8A and neoplasm: Repurposing inducible systems such as synthetic Notch receptors, degron technologies, and site-specific knock-ins, to modulate the expression of transcription factors that drive superior anti-tumour CD8+ T cell responses may be promising approaches for achieving dynamic transcriptional modulation.